Clinical Trials
2 trialsNCT01681433 2022-07-11
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Hoosier Cancer Research Network
Phase 2 Terminated
NCT01120470 2019-02-15
OGX-427 in Castration Resistant Prostate Cancer Patients
British Columbia Cancer Agency
Phase 2 Completed